-+ 0.00%
-+ 0.00%
-+ 0.00%

Purple Biotech announces annual shareholder meeting

PUBT·07/29/2026 20:25:59
Listen to the news
Purple Biotech announces annual shareholder meeting
  • Purple Biotech will hold its annual shareholder meeting in Rehovot, Israel on Sept. 8, 2026.
  • Shareholders will vote on electing Gil Efron and Yael Margolin as second-class directors, with terms running to the 2029 annual meeting.
  • A separate vote will cover compensation for Efron as executive director, head of corporate development, effective Aug. 31, 2026.
  • Investors will also vote on adopting an amended compensation policy for executive officers and directors for a three-year term.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Purple Biotech Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-082792), on July 29, 2026, and is solely responsible for the information contained therein.